Kynda Biotech

Kynda Biotech

Private
GermanyEnergy & Sustainabilityhttps://www.kyndatech.com/

Last Round

Seed

Feb 19, 2025

Total Funding Raised

$3.26M

Momentum Score

50 /100

Company Overview

Kynda Biotech GmbH, formerly known as Keen 4 Greens GmbH, is a German biotechnology company founded in 2019 that specializes in biomass fermentation. The company has developed a proprietary, low-cost, 'plug-and-play' bioreactor system that enables partners in the food and pet food industries to produce mycoprotein in-house. Kynda's process upcycles agricultural by-products, using fungal fermentation to create a sustainable, clean-label alternative protein that has a meat-like texture and is rich in fiber and amino acids. The company aims to decentralize and improve the sustainability of protein production. Kynda has raised funding from investors including the PHW Group, a major poultry processor, to scale up production at its facility in Jelmstorf, Germany.

Sector

Energy & Sustainability

Verticals

Sustainable Materials, Biotech Equipment, Biotechnology

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Non-AI

Keywords

mycoproteinbiomass fermentationalternative proteinsfungal proteinB2B ingredientsfood techsustainable proteinfermentation techupcyclingcircular economypet food ingredientsagricultural side-streamsplug-and-play bioreactorsfermentation hardwaredecentralized productionstarter cultures

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kynda Biotech Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Kynda Biotech Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 19, 2025
GrantNov 20, 2023

Key People

Founding team and executive leadership

Franziskus Schnabel

Co-Founder COO, Co Founder And COO

Founding Team

Kynda Biotech Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 22, 2026

    Added EIT Food, a food and agriculture SMB, as a customer.

  • Feb 19, 2025

    Raised $3.3M in a seed funding round.

Kynda Biotech Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Kynda Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kynda Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersGermany
Employee Range16
Year Founded2019
Last FundingFeb 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.